Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act

7/24/2024, 3:13 PM

Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson's Act

This bill requires the Department of Health and Human Services (HHS) to carry out a project to address Parkinson's disease (a progressive brain disorder that causes unintended or uncontrollable movements) and related conditions.

Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent, diagnose, treat, and cure the disease; and (2) improve the care of those with the disease. HHS must also annually assess the preparations for and response to the increased burden of Parkinson's disease.

In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and treatment of Parkinson's disease.

The provisions of the bill terminate at the end of calendar year 2035.

Bill 118 hr 2365, also known as the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act, is a piece of legislation introduced in the US Congress with the goal of creating a national plan to combat Parkinson's disease. The bill is named after Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton, who are both advocates for Parkinson's research and treatment.

The main objective of the bill is to establish a comprehensive strategy to address the challenges faced by individuals living with Parkinson's disease. This includes improving access to care, increasing funding for research, and promoting education and awareness about the disease. The bill also aims to enhance coordination among federal agencies, healthcare providers, and advocacy organizations to ensure a unified approach to tackling Parkinson's.

Additionally, the bill calls for the creation of a Parkinson's Disease Council, which will be responsible for developing and implementing the national plan. The council will consist of experts in the field of Parkinson's research, healthcare providers, and individuals living with the disease. Overall, the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act seeks to improve the quality of life for individuals affected by Parkinson's disease and ultimately work towards finding a cure. It represents a bipartisan effort to address a pressing public health issue and highlights the importance of collaboration and innovation in the fight against Parkinson's.
Congress
118
Number
HR - 2365
Introduced on
2023-03-29
# Amendments
0
Sponsors
+5
Cosponsors
+5

Variations and Revisions

Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
Passed in House
Introduced to Senate
Passed in Senate
To President
Signed by President
Became Public Law

Purpose and Summary

Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson's Act

This bill requires the Department of Health and Human Services (HHS) to carry out a project to address Parkinson's disease (a progressive brain disorder that causes unintended or uncontrollable movements) and related conditions.

Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent, diagnose, treat, and cure the disease; and (2) improve the care of those with the disease. HHS must also annually assess the preparations for and response to the increased burden of Parkinson's disease.

In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and treatment of Parkinson's disease.

The provisions of the bill terminate at the end of calendar year 2035.

Bill 118 hr 2365, also known as the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act, is a piece of legislation introduced in the US Congress with the goal of creating a national plan to combat Parkinson's disease. The bill is named after Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton, who are both advocates for Parkinson's research and treatment.

The main objective of the bill is to establish a comprehensive strategy to address the challenges faced by individuals living with Parkinson's disease. This includes improving access to care, increasing funding for research, and promoting education and awareness about the disease. The bill also aims to enhance coordination among federal agencies, healthcare providers, and advocacy organizations to ensure a unified approach to tackling Parkinson's.

Additionally, the bill calls for the creation of a Parkinson's Disease Council, which will be responsible for developing and implementing the national plan. The council will consist of experts in the field of Parkinson's research, healthcare providers, and individuals living with the disease. Overall, the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act seeks to improve the quality of life for individuals affected by Parkinson's disease and ultimately work towards finding a cure. It represents a bipartisan effort to address a pressing public health issue and highlights the importance of collaboration and innovation in the fight against Parkinson's.
Alternative Names
Official Title as IntroducedTo direct the Secretary of Health and Human Services to carry out a national project to prevent and cure Parkinson's, to be known as the National Parkinson's Project, and for other purposes.
Policy Areas
Health
Potential Impact
Advisory bodies•
Congressional oversight•
Government information and archives•
Health promotion and preventive care•
Neurological disorders

Comments

Related

Member:  
Victoria Spartz
Member:  
Frank J. Mrvan
Member:  
Kevin Mullin
Member:  
Nicholas A. Langworthy
Member:  
Zoe Lofgren

Recent Activity

Latest Summary7/17/2024

Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson's Act

This bill requires the Department of Health and Human Services (HHS) to carry out a project to address Parkinson's disease (a progress...

Latest Action7/2/2024
Became Public Law No: 118-66.